reportingrisk.com← the monitorSEC reporting failures, scored and checked against what happened next

Or browse all companies A–Z.

OS Therapies Inc

OSTX · NYSE

1 reporting failure in the last 12 months

Companies at this level ended the following year delisted, bankrupt, restated or silent 9.2% of the time, against 4.0% for companies with a clean record.

$50Mpublic float
2026-05-15most recent failure

Score over time

0122024202520262024-07-01 · score 12024-05-15 filed late (10-K) · accounts not ready2024-10-01 · score 12024-05-15 filed late (10-K) · accounts not ready2025-01-01 · score 22024-11-14 filed late (10-Q) · accounts not ready2024-05-15 filed late (10-K) · accounts not ready2025-04-01 · score 22024-11-14 filed late (10-Q) · accounts not ready2024-05-15 filed late (10-K) · accounts not ready2025-07-01 · score 12024-11-14 filed late (10-Q) · accounts not ready2025-10-01 · score 22025-08-15 filed late (10-Q) · accounts not ready2024-11-14 filed late (10-Q) · accounts not ready2026-01-01 · score 12025-08-15 filed late (10-Q) · accounts not ready2026-04-01 · score 12025-08-15 filed late (10-Q) · accounts not ready2026-07-01 · score 22026-05-15 filed late (10-Q) · accounts not ready2025-08-15 filed late (10-Q) · accounts not ready2026-10-01 · score 12026-05-15 filed late (10-Q) · accounts not ready

Hover or tap a dot to see the filings behind that score.

Why they said they were late

OS Therapies Incorporated (the “Company”) has determined that it will not be able to file its Quarterly Report on Form 10-Q for its quarter ended March 31, 2026 (the “Form 10-Q”) by May 15, 2026, the original due date for such filing, without unreasonable effort or expense, due to delays in compiling and reviewing certain information included in the Form 10-Q resulting primarily from additional time required for the Company to complete the financial statement close process. The Company expects to file the Form 10-Q within the extension period of five calendar days, as provided under Rule 12b-25 under the Securities Exchange Act of 1934, as amended

NT 10-Q, filed 2026-05-15 · accounts not ready

What it filed

2026-05-15filed late (10-Q)accounts not ready SEC →

OS Therapies Incorporated (the “Company”) has determined that it will not be able to file its Quarterly Report on Form 10-Q for its quarter ended March 31, 2026 (the “Form 10-Q”) by May 15, 2026, the original due date for such filing, without unreasonable effort or expense, due to delays in compiling and reviewing certain information included in the Form 10-Q resulting primarily from additional time required for the Company to complete the financial statement close process. The Company expects to file the Form 10-Q within the extension period of five calendar days, as provided under Rule 12b-25 under the Securities Exchange Act of 1934, as amended

2025-08-15filed late (10-Q)accounts not ready SEC →

OS Therapies Incorporated (the “Company”) has determined that it will not be able to file its Quarterly Report on Form 10-Q for its quarter ended June 30, 2025 (the “Form 10-Q”) by August 14, 2025, the original due date for such filing, without unreasonable effort or expense, due to delays in compiling and reviewing certain information included in the Form 10-Q resulting primarily from additional time required for the Company to complete the financial statement close process. The Company expects to file the Form 10-Q within the extension period of five calendar days, as provided under Rule 12b-25 under the Securities Exchange Act of 1934, as amended

2024-11-14filed late (10-Q)accounts not ready SEC →

OS Therapies Incorporated (the “Company”) has determined that it will not be able to file its Quarterly Report on Form 10-Q for its quarter ended September 30, 2024 (the “Form 10-Q”) by November 14, 2024, the original due date for such filing, without unreasonable effort or expense, due to delays in compiling and reviewing certain information included in the Form 10-Q resulting primarily from additional time required for the Company to complete the financial statement close process. The Company expects to file the Form 10-Q within the extension period of five calendar days, as provided under Rule 12b-25 under the Securities Exchange Act of 1934, as amended

2024-05-15filed late (10-Q)accounts not ready SEC →

OS Therapies Incorporated (the “Company”) has determined that it will not be able to file its Quarterly Report on Form 10-Q for its quarter ended March 31, 2024 (the “Form 10-Q”) by May 15, 2024, the original due date for such filing, without unreasonable effort or expense, due to delays in compiling and reviewing certain information included in the Form 10-Q resulting primarily from additional time required for the Company to complete the financial statement close process. The Company expects to file the Form 10-Q within the extension period of five calendar days, as provided under Rule 12b-25 under the Securities Exchange Act of 1934, as amended

2024-05-15filed late (10-K)accounts not ready SEC →

OS Therapies Incorporated (the “Company”) has determined that it will not be able to file its Special Financial Report on Form 10-K for its fiscal year ended December 31, 2023 (the “Special Financial Report”), pursuant to Rule 15d-2 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), by May 14, 2024, the original due date for such filing, without unreasonable effort or expense, due to delays in compiling and reviewing certain information included in the Special Financial Report resulting primarily from additional time required for the Company to complete the financial statement close process. The Company expects to file the Special Financial Report within the extension period of 15 calendar days, as provided under Rule 12b-25 under the Exchange Act

About this score

reportingrisk.com scores every active US filer on three things a company tells the SEC about itself: late-filing notices on Form NT, 8-K item 4.02 (past accounts declared unreliable) and 4.01 (auditor changes). 1,012 are flagged today.

Every score is frozen and checked twelve months later. Across 91,452 of them, a company scoring 4 or more ended that year delisted, bankrupt, restated or silent 17.2% of the time, against 4.0% for a clean record. Scores before 2026-09-27 were reconstructed from the filing history as it stood at each date, so the record is a backtest rather than years of live calls.

See the ledger → Every company the score flagged that later failed, what it told the SEC on the way down, and the ones it missed.

Every item above is a filing this company made with the SEC.
Snapshot 2026-11-04 · data from SEC EDGAR (public domain) · not investment advice

reportingrisk.com← back to the monitorAll companies A-Z · RSS · found an error? hello@reportingrisk.com